Member Monday: July 1, 2019

Hollings Cancer Center in Charleston, S.C.

Every other Monday, ACCC highlights the latest news, announcements, resources, and innovations from our member cancer programs. To submit your program, visit the Member News Submission Portal and complete a brief form.

A Home for Precision Medicine in San Francisco

Last week, the University of San Francisco Helen Diller Family Comprehensive Cancer Center opened the Bakar Precision Cancer Medicine Building, a $275-million cancer center that will feature 120 exam rooms, 47 infusion bays, and more than a dozen imaging options.

The Future of Immunotherapy in South Carolina

Congratulations to Hollings Cancer Center! Researchers there have received a $3 million grant from the National Cancer Institute to continue research into the combination of the checkpoint drug nivolumab and ALT-803 to treat patients with lung cancer.

Putting on the Final Touches in Kentucky

St. Elizabeth Healthcare has placed the final beam on its new $130 million cancer center! The five-story facility will bring advanced treatment to northern Kentucky for the first time in collaboration with the Markey Cancer Center at the University of Kentucky.

Addressing Immune-Related Toxicity in Baltimore

In the June 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network, Johns Hopkins Kimmel Cancer Center published research that suggests that cancer programs utilizing immunotherapy should establish multidisciplinary teams for coordinating the management of immunotherapy-related adverse events (irAEs).